Open Market Insiders Trades - Sells only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
DASH
|
Tony Xu
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct | 16,667 Reduced 91.74% |
$3,833,410
$230.0 p/Share
|
Jan 05
2026 |
|
NTLA
|
Birgit C Schultes
EVP, Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 8,508 Reduced 7.95% |
$78,358
$9.21 p/Share
|
Jan 05
2026 |
|
TVTX
|
Jula Inrig
CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct | 2,031 Reduced 2.29% |
$81,605
$40.18 p/Share
|
Jan 05
2026 |
|
NTLA
|
John M Leonard
President and CEO |
SELL
Open market or private sale
|
Direct | 34,146 Reduced 3.26% |
$314,484
$9.21 p/Share
|
Jan 05
2026 |
|
BFLY
|
Victor Ku
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 35,968 Reduced 4.24% |
$137,397
$3.82 p/Share
|
Jan 05
2026 |
|
CSTL
|
Derek J Maetzold
Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct | 2,678 Reduced 7.99% |
$102,005
$38.09 p/Share
|
Jan 05
2026 |
|
EYPT
|
Ramiro Ribeiro
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 42,544 Reduced 100.0% |
$727,502
$17.1 p/Share
|
Jan 05
2026 |
|
IDCC
|
Rajesh Pankaj
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 1.58% |
$326,750
$326.75 p/Share
|
Jan 05
2026 |
|
IDCC
|
Richard Brezski
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 6,981 Reduced 7.73% |
$2,284,183
$327.2 p/Share
|
Jan 05
2026 |
|
NTLA
|
Michael P Dube
VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 2,989 Reduced 5.41% |
$27,528
$9.21 p/Share
|
Jan 05
2026 |
|
NTLA
|
Edward J Dulac Iii
EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 6,379 Reduced 6.01% |
$58,750
$9.21 p/Share
|
Jan 05
2026 |
|
RKT
|
Matthew Rizik
Director |
SELL
Open market or private sale
|
Direct | 2,500 Reduced 0.24% |
$52,600
$21.04 p/Share
|
Jan 05
2026 |
|
INCY
|
Steven H Stein
EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 15,634 Reduced 31.37% |
$1,589,977
$101.7 p/Share
|
Jan 05
2026 |
|
CTSH
|
Michael Patsalos Fox
Director |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 8.64% |
$245,730
$81.91 p/Share
|
Jan 05
2026 |
|
DDOG
|
Alexis Le Quoc
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 43,106 Reduced 12.51% |
$5,795,601
$134.45 p/Share
|
Jan 05
2026 |
|
NTLA
|
Eliana Clark
EVP, Chief Technical Officer |
SELL
Open market or private sale
|
Direct | 9,515 Reduced 9.85% |
$87,633
$9.21 p/Share
|
Jan 05
2026 |
|
NTLA
|
David Lebwohl
EVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 11,903 Reduced 8.94% |
$109,626
$9.21 p/Share
|
Jan 05
2026 |
|
WAB
|
Rafael Santana
President and CEO |
SELL
Open market or private sale
|
Direct | 1,798 Reduced 1.45% |
$391,586
$217.79 p/Share
|
Jan 05
2026 |
|
CCK
|
Timothy J Donahue
President & CEO |
SELL
Open market or private sale
|
Direct | 29,024 Reduced 6.59% |
$3,047,520
$105.0 p/Share
|
Jan 05
2026 |
|
BCV
|
Mario J Gabelli
Director |
SELL
Open market or private sale
|
Indirect | 1,300 Reduced 0.0% |
$28,925
$22.25 p/Share
|
Jan 05
2026 |
|
ACTU
|
Todd S Thomson |
SELL
Open market or private sale
|
Indirect | 280,000 Reduced 0.0% |
$1,624,000
$5.8 p/Share
|
Jan 05
2026 |
|
FNF
|
Halim Dhanidina
Director |
SELL
Open market or private sale
|
Direct | 6,000 Reduced 31.27% |
$335,400
$55.9 p/Share
|
Jan 05
2026 |
|
CPT
|
Laurie Baker
EVP - Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 531 Reduced 0.55% |
$58,282
$109.76 p/Share
|
Jan 05
2026 |
|
CPT
|
Javier Benito |
SELL
Open market or private sale
|
Direct | 101 Reduced 1.27% |
$11,078
$109.69 p/Share
|
Jan 05
2026 |
|
CPT
|
Heather J. Brunner |
SELL
Open market or private sale
|
Direct | 2,104 Reduced 17.09% |
$230,787
$109.69 p/Share
|
Jan 05
2026 |
|
CPT
|
Kelvin R Westbrook |
SELL
Open market or private sale
|
Direct | 2,225 Reduced 7.13% |
$244,060
$109.69 p/Share
|
Jan 05
2026 |
|
CPT
|
Alexander J. Jessett
President & CFO |
SELL
Open market or private sale
|
Direct | 5,627 Reduced 3.82% |
$617,225
$109.69 p/Share
|
Jan 05
2026 |
|
CPT
|
Richard J Campo
Chairman and CEO |
SELL
Open market or private sale
|
Direct | 38,021 Reduced 11.21% |
$4,173,184
$109.76 p/Share
|
Jan 05
2026 |
|
HURN
|
Ekta Singh Bushell
Director |
SELL
Open market or private sale
|
Direct | 126 Reduced 0.88% |
$21,532
$170.89 p/Share
|
Jan 05
2026 |
|
HURN
|
Debra Zumwalt
Director |
SELL
Open market or private sale
|
Direct | 170 Reduced 0.64% |
$29,051
$170.89 p/Share
|
Jan 05
2026 |
|
HURN
|
Hugh E Sawyer Iii
Director |
SELL
Open market or private sale
|
Direct | 136 Reduced 0.63% |
$23,241
$170.89 p/Share
|
Jan 05
2026 |
|
DRS
|
Sally Wallace
EVP, Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 1,300 Reduced 2.18% |
$45,721
$35.17 p/Share
|
Jan 05
2026 |
|
DRS
|
Michael Dippold
EVP and CFO |
SELL
Open market or private sale
|
Direct | 10,588 Reduced 19.78% |
$391,756
$37.0 p/Share
|
Jan 05
2026 |
|
DRS
|
Mark Dorfman
EVP, GC and Secretary |
SELL
Open market or private sale
|
Direct | 7,680 Reduced 21.72% |
$284,160
$37.0 p/Share
|
Jan 05
2026 |
|
KTOS
|
Eric M Demarco
President & CEO |
SELL
Open market or private sale
|
Indirect | 8,301 Reduced 0.0% |
$747,090
$90.0 p/Share
|
Jan 05
2026 |
|
ANAB
|
Paul F. Lizzul
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 4,219 Reduced 11.24% |
$182,513
$43.26 p/Share
|
Jan 05
2026 |
|
ANAB
|
Dennis Mulroy
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 3,363 Reduced 19.01% |
$145,483
$43.26 p/Share
|
Jan 05
2026 |
|
ANAB
|
Daniel Faga
President, CEO |
SELL
Open market or private sale
|
Direct | 15,309 Reduced 3.23% |
$662,267
$43.26 p/Share
|
Jan 05
2026 |
|
EVCM
|
Matthew David Feierstein
President |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 0.48% |
$116,600
$11.66 p/Share
|
Jan 05
2026 |
|
ANAB
|
Eric J Loumeau
CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct | 2,983 Reduced 18.38% |
$129,044
$43.26 p/Share
|
Jan 05
2026 |
|
RM
|
Forager Fund, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 8,827 Reduced 0.82% |
$353,874
$40.09 p/Share
|
Jan 05
2026 |
|
SRZN
|
Yang Li
Exec. Vice President, Research |
SELL
Open market or private sale
|
Direct | 1,118 Reduced 6.5% |
$22,214
$19.87 p/Share
|
Jan 05
2026 |
|
TERN
|
Amy L. Burroughs
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 71,339 Reduced 33.92% |
$2,718,015
$38.1 p/Share
|
Jan 05
2026 |
|
SRZN
|
Charles O Williams
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 1,566 Reduced 10.76% |
$31,116
$19.87 p/Share
|
Jan 05
2026 |
|
BCYC
|
Kevin Lee
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct | 10,989 Reduced 1.74% |
$70,988
$6.46 p/Share
|
Jan 05
2026 |
|
BCYC
|
Alethia Young
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 4,334 Reduced 4.74% |
$28,171
$6.5 p/Share
|
Jan 05
2026 |
|
BCYC
|
Alistair Milnes
CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct | 3,416 Reduced 2.44% |
$22,067
$6.46 p/Share
|
Jan 05
2026 |
|
BCYC
|
Michael Charles Ferguson Hannay
CHIEF PROD & SUPPLY CHAIN OFF |
SELL
Open market or private sale
|
Direct | 2,367 Reduced 2.36% |
$15,267
$6.45 p/Share
|
Jan 05
2026 |
|
BCYC
|
Michael Skynner
CHIEF TECHNOLOGY OFFICER |
SELL
Open market or private sale
|
Direct | 3,266 Reduced 1.98% |
$21,098
$6.46 p/Share
|
Jan 05
2026 |
|
BCYC
|
Travis Alvin Thompson
CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct | 1,115 Reduced 1.65% |
$7,191
$6.45 p/Share
|
Jan 05
2026 |